Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiqing Liu

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
British Journal of Haematology|September 21, 2023
Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experiencePeijing Qi, Linya Wang, Hongqiao Li, et al.
Annals of Hematology|August 30, 2024
Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period-a retrospective study in two medical centersQingyuan Xu, Hongqiao Li, Pengli Huang, et al.
Nature Communications|April 20, 2018
TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory painYan Wang, Yingwei Gao, Quan Tian, et al.
Nature Communications|June 30, 2018
Author Correction: TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory painYan Wang, Yingwei Gao, Quan Tian, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Frontiers in Immunology|December 5, 2022
Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patientsShirin Emtenani, Maike M Holtsche, Richard Stahlkopf, et al.
NPJ Precision Oncology|November 3, 2024
Remission rate, toxicity and pharmacokinetics of venetoclax-based induction regimens in untreated pediatric acute myeloid leukemiaXiaojia Wen, Yu Lu, Yanming Li, et al.
Cancer Cell|June 28, 2002
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingEng-Juh Yeoh, Mary E Ross, Sheila A Shurtleff, et al.
Science Translational Medicine|November 15, 2023
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse modelsShuaiya Ma, Ye Tian, Jiali Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination StrategiesMatthew C Stubbs, Timothy C Burn, Richard Sparks, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
British Journal of Haematology|September 21, 2023
Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experiencePeijing Qi, Linya Wang, Hongqiao Li, et al.
Annals of Hematology|August 30, 2024
Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period-a retrospective study in two medical centersQingyuan Xu, Hongqiao Li, Pengli Huang, et al.
Nature Communications|April 20, 2018
TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory painYan Wang, Yingwei Gao, Quan Tian, et al.
Nature Communications|June 30, 2018
Author Correction: TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory painYan Wang, Yingwei Gao, Quan Tian, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Frontiers in Immunology|December 5, 2022
Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patientsShirin Emtenani, Maike M Holtsche, Richard Stahlkopf, et al.
NPJ Precision Oncology|November 3, 2024
Remission rate, toxicity and pharmacokinetics of venetoclax-based induction regimens in untreated pediatric acute myeloid leukemiaXiaojia Wen, Yu Lu, Yanming Li, et al.
Cancer Cell|June 28, 2002
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingEng-Juh Yeoh, Mary E Ross, Sheila A Shurtleff, et al.
Science Translational Medicine|November 15, 2023
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse modelsShuaiya Ma, Ye Tian, Jiali Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination StrategiesMatthew C Stubbs, Timothy C Burn, Richard Sparks, et al.
Pageof 15